{"filing":{"accession_number":"0001193125-26-257432","cik":"0001802768","ticker":"RPRX","company_name":"Royalty Pharma plc","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"d855771d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1802768/000119312526257432/d855771d8k.htm"},"events":[{"id":6815,"run_id":5972,"accession_number":"0001193125-26-257432","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from Royalty Pharma's 2026 Annual General Meeting held on June 4, 2026. The filing presents detailed vote tabulations for all 10 proposals submitted to shareholders, including director elections, executive compensation approval, auditor ratification, and share authorization matters. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose directly reports the inspector of election's certified vote counts for each proposal.","company_name":"Royalty Pharma plc","ticker":"RPRX","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":[{"id":4345,"accession_number":"0001193125-26-257432","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Royalty Pharma's 2026 Annual General Meeting held on June 4, 2026. The filing presents detailed vote tabulations for all 10 proposals submitted to shareholders, including director elections, executive compensation approval, auditor ratification, and share authorization matters. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose directly reports the inspector of election's certified vote counts for each proposal.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T04:58:16.256602+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4345,"accession_number":"0001193125-26-257432","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Royalty Pharma's 2026 Annual General Meeting held on June 4, 2026. The filing presents detailed vote tabulations for all 10 proposals submitted to shareholders, including director elections, executive compensation approval, auditor ratification, and share authorization matters. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose directly reports the inspector of election's certified vote counts for each proposal.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T04:58:16.256602+00:00","company_name":"Royalty Pharma plc","ticker":"RPRX","filing_date":"2026-06-04"}]}